The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment
Open accessAbstract
Western Cambodia is recognized as the epicenter of Plasmodium falciparum multidrug resistance. Recent reports of the efficacy of dihydroartemisinin (DHA)-piperaquine (PP), the latest of the artemisinin-based combination therapies (ACTs) recommended by the WHO, have prompted further investigations. The clinical efficacy of dihydroartemisinin-piperaquine in uncomplicated falciparum malaria was assessed in western and eastern Cambodia over 42 days. Day 7 plasma piperaquine concentrations were measured and day 0 isolates tested for in vitro susceptibilities to piperaquine and mefloquine, polymorphisms in the K13 gene, and the copy number of the Pfmdr-1 gene. A total of 425 patients were recruited in 2011 to 2013. The proportion of patients with recrudescent infections was significantly higher in western (15.4%) than in eastern (2.5%) Cambodia ( P <10 −3 ). Day 7 plasma PP concentrations and median 50% inhibitory concentrations (IC 50 ) of PP were independent of treatment outcomes, in contrast to median mefloquine IC 50 , which were found to be lower for isolates from patients with recrudescent infections (18.7 versus 39.7 nM; P = 0.005). The most significant risk factor associated with DHA-PP treatment failure was infection by parasites carrying the K13 mutant allele (odds ratio [OR], 17.5; 95% confidence interval [CI], 1 to 308; P = 0.04). Our data show evidence of P. falciparum resistance to PP in western Cambodia, an area of widespread artemisinin resistance. New therapeutic strategies, such as the use of triple ACTs, are urgently needed and must be tested. (This study has been registered at the Australian New Zealand Clinical Trials Registry under registration no. ACTRN12614000344695.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424
Self-citationA molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Ariey, F., Witkowski, B., Amaratunga, C., Beghain, J., Langlois, A.-C., Khim, N., Kim, S., Duru, V., Bouchier, C., Ma, L., et al. (2014) · Nature · doi:10.1038/nature12876 · Cited by 2,090
Self-citationEvidence of Artemisinin-Resistant Malaria in Western Cambodia
Noedl, H., Se, Y., Schaecher, K., Smith, B. L., Socheat, D., & Fukuda, M. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0805011 · Cited by 1,785
Amaratunga, C., Sreng, S., Suon, S., Phelps, E. S., Stepniewska, K., Lim, P., Zhou, C., Mao, S., Anderson, J. M., Lindegardh, N., et al. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70181-0 · Cited by 344
Spring, M. D., Lin, J. T., Manning, J. E., Vanachayangkul, P., Somethy, S., Bun, R., Se, Y., Chann, S., Ittiverakul, M., Sia-ngam, P., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70049-6 · Cited by 244
Dihydroartemisinin–Piperaquine Failure in Cambodia
Saunders, D. L., Vanachayangkul, P., & Lon, C. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1403007 · Cited by 225
Snounou, G., & Beck, H.-P. (1998) · Parasitology Today · doi:10.1016/s0169-4758(98)01340-4 · Cited by 215
Leang, R., Barrette, A., Bouth, D. M., Menard, D., Abdur, R., Duong, S., & Ringwald, P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00686-12 · Cited by 185
Self-citationDenis, M. B., Tsuyuoka, R., Lim, P., Lindegårdh, N., Yi, P., Narann, T. S., Socheat, D., Fandeur, T., Annerberg, A., Christophel, E. M., et al. (2006) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2006.01739.x · Cited by 149
Self-citationDenis, M. B., Tsuyuoka, R., Yi, P., Narann, T. S., Suon, S., Lim, C., Incardona, S., Lim, P., Sem, R., Socheat, D., et al. (2006) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2006.01690.x · Cited by 138
Self-citationOrigin and Evolution of Sulfadoxine Resistant Plasmodium falciparum
Vinayak, S., Alam, T., Mixson-Hayden, T. R., McCollum, A. M., Sem, R., Shah, N. K., Lim, P., Muth, S., Rogers, W. O., Fandeur, T., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000830 · Cited by 132
Thriemer, K., Hong, N. V., Rosanas‐Urgell, A., Phuc, B. Q., Ha, D. M., Pockele, E., Guetens, P., Van, N. V., Duong, T. T., Amambua‐Ngwa, A., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02746-14 · Cited by 106
Zwang, J., Ashley, E. A., Karema, C., D’Alessandro, U., Smithuis, F. M., Dorsey, G., Janssens, B., Mayxay, M., Newton, P. N., Singhasivanon, P., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006358 · Cited by 102
Price, R. N., Hasugian, A. R., Ratcliff, A., Siswantoro, H., Purba, H., Kenangalem, E., Lindegårdh, N., Penttinen, P. M., Laihad, F., Ebsworth, E. P., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00486-07 · Cited by 97
Simplified antimalarial therapeutic monitoring: using the day-7 drug level?
White, N. J., Stepniewska, K., Barnes, K. I., Price, R. N., & Simpson, J. A. (2008) · Trends in Parasitology · doi:10.1016/j.pt.2008.01.006 · Cited by 93
Effects of a High-Fat Meal on the Relative Oral Bioavailability of Piperaquine
Sim, I.-K., Davis, T. M. E., & Ilett, K. F. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2407-2411.2005 · Cited by 90
Janssens, B., Herp, M. V., Goubert, L., Chan, S., Uong, S., Nong, S., Socheat, D., Brockman, A., Ashley, E. A., & Damme, W. V. (2007) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2006.01786.x · Cited by 61
Meek, S. R., Doberstyn, E. B., Gaüzère, B.-A., Thanapanich, C., Nordlander, E., & Phuphaisan, S. (1986) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1986.35.246 · Cited by 61
Pharmacokinetics of the Antimalarial Drug Piperaquine in Healthy Vietnamese Subjects
Chinh, N. T., Quang, N. N., Thanh, N. X., Dai, B., Travers, T., & Edstein, M. D. (2008) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2008.79.620 · Cited by 43
Bustos, Wongsrichanalai, C., Delacollette, C., & Burkholder, B. (2013) · PubMed · Cited by 41
Lim, P., Dek, D., Try, V., Eastman, R. T., Chy, S., Sreng, S., Suon, S., Mao, S., Sopha, C., Sam, B., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00687-13 · Cited by 40
Self-citationLiu, H., Yang, H., Tang, L.-H., Li, X.-L., Huang, F. J., Wang, J., Li, C., Wang, H.-Y., Nie, R.-H., Guo, X.-R., et al. (2015) · Malaria Journal · doi:10.1186/s12936-015-0584-8 · Cited by 40
High throughput assay for the determination of piperaquine in plasma
Lindegårdh, N., White, N. J., & Day, N. (2005) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2005.03.031 · Cited by 36
Lim, P., Dek, D., Try, V., Sreng, S., Suon, S., & Fairhurst, R. M. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05163-14 · Cited by 34
Nurhayati, Tjitra, E., Trihono, Hasugian, A. R., Siswantoro, H., Prasetyorini, B., Ekowatiningsih, R., Yusnita, E. A., Purnamasari, T., Driyah, S., et al. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-153 · Cited by 34
Lim, P., Chim, P., Sem, R., Nemh, S., Yi, P., Lim, C., Seila, S., Tsuyuoka, R., Denis, M. B., Socheat, D., et al. (2004) · Acta Tropica · doi:10.1016/j.actatropica.2004.09.002 · Cited by 33
Gargano, N., Ubben, D., Tommasini, S., Bacchieri, A., Corsi, M., Bhattacharyya, P. C., Rao, B. H. K., Dubashi, N., Dev, V., Ghosh, S. K., et al. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-233 · Cited by 25
Zongo, I., Somé, A. F., SOMDA, S. M. A., Parikh, S., Rouamba, N., Rosenthal, P. J., Tärning, J., Lindegårdh, N., Nosten, F. H., & Ouédraogo, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103200 · Cited by 23
Xb, G. (1993) · PubMed · Cited by 18
Cited by
New developments in anti-malarial target candidate and product profiles
Burrows, J. N., Duparc, S., Gutteridge, W. E., Hooft van Huijsduijnen, R., Kaszubska, W., Macintyre, F., Mazzuri, S., Möhrle, J. J., & Wells, T. N. C. (2017) · Malaria Journal · doi:10.1186/s12936-016-1675-x · Cited by 520
Antimalarial Drug Resistance: A Threat to Malaria Elimination
Menard, D., & Dondorp, A. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025619 · Cited by 499
Self-citationAmaratunga, C., Lim, P., Suon, S., Sreng, S., Mao, S., Sopha, C., Sam, B., Dek, D., Try, V., Amato, R., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00487-9 · Cited by 493
Self-citationImwong, M., Suwannasin, K., Kunasol, C., Sutawong, K., Mayxay, M., Rekol, H., Smithuis, F. M., Hlaing, T. M., Tun, K. M., van der Pluijm, R. W., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30048-8 · Cited by 484
Self-citationAmato, R., Lim, P., Miotto, O., Amaratunga, C., Dek, D., Pearson, R. D., Almagro-Garcia, J., Neal, A. T., Sreng, S., Suon, S., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30409-1 · Cited by 401
Metadata
- Authors
- Leang, R., Taylor, W. R. J., Bouth, D. M., Song, L., Tarning, J., Char, M. C., Kim, S., Witkowski, B., Duru, V., Domergue, A., Khim, N., Ringwald, P., & Menard, D.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2015-08
- Volume
- 59
- Issue
- 8
- Pages
- 4719-4726
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2169329132
- Cited by
- 302
- References
- 29
- FWCI
- 40.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.